Mid-Term Natural Course Postoperative of Crowe Type III-IV Hip Dysplasia

Hip Arthropathy Clinical Trial

Official title:

Mid-Term Natural Course of Lower Extremity and Spine After Total Hip Arthroplasty in Patients With Crowe Type III-IV Hip Dysplasia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05149729
• Other study ID #: E.16313
• Status: Recruiting
• Phase: N/A
• Start date: February 10, 2021
• Est. completion date: June 10, 2024

Study information

• Verified date: December 2021
• Source: Bezmialem Vakif University
• Contact: hakan batuhan kaya
• Phone: 00905542294339
• Email: hbatuhan-kaya-123[@]hotmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Comparison of preoperative and postoperative mid-term course of patients with Crowe Type 3 and Type 4 hip dysplasia.

Description:

Crowe type 3 and type 4 patients who underwent shortened hip replacement surgery will be followed up for 2 years.

Patients will be called for routine outpatient controls at the 2nd week, 6th week, 3rd month, 6th month, 12th month, 24th month.

Patients will be referred to the physical therapy specialist for abduction strengthening and pelvis tilt corrective exercises starting from the 6th week.

Scoliosis and orthoroentgenography x-rays will be taken at the last control of the patients.

HHS, WOMAC hip score and SF-12 score will be obtained from the patients. Scores, lower extremity and spine angles will be evaluated after the last examinations performed at 12 and 24 months.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: June 10, 2024
• Est. primary completion date: May 10, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Crowe type 3 and 4 patients over 18 years of age who had shortened hip replacement surgery

Exclusion Criteria:

• Crowe type 1 or 2 patients over 18 years of age who had shortened hip replacement surgery

• Patients who have previously operated on the contralateral hip

• Patients who underwent shortened hip replacement for a reason other than developmental dysplasia of the hip

Related Conditions & MeSH terms

• Developmental Dysplasia of the Hip
• Hip Arthropathy
• Hip Dislocation
• Hip Dislocation, Congenital
• Hip Dysplasia
• Joint Diseases

Intervention

Procedure:
• Shortened hip arthroplasty
Crowe type 3 and 4 patients who underwent shortened hip prosthesis

Locations

Country	Name	City	State
Turkey	Bezmialem Vakif University	Istanbul	Fatih

Sponsors (1)

Lead Sponsor	Collaborator
Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)	The WOMAC score range, which indicates the clinical satisfaction of the patients, is between 0-100.	The degree of improvement in Vomac score will be evaluated by looking at preoperative and postoperative 12th month Vomac scores.( 0-12th month )

External Links

•   CHANGES IN HIP, KNEE, AND ANKLE CORONAL ALIGNMENTS AFTER TOTAL HIP ARTHROPLASTY WITH TRANSVERSE FEMORAL SHORTENING OSTEOTOMY FOR UNILATERAL CROWE TYPE IV DEVELOPMENTAL DYSPLASIA OF THE HIP
•   EFFECTS OF TOTAL HIP ARTHROPLASTY ON AXIAL ALIGNMENT